GILT study: Oral vinorelbine (NVBo) and cisplatin (P) with concomitant radiotherapy (RT) followed by either consolidation (C) with NVBo plus P plus best supportive care (BSC) or BSC alone in stage (st) III non-small cell lung cancer (NSCLC): Final results

Reporter: Annemarie Fernandes
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 4 de junio del 2012

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

ASCO: Low-Dose CT Lung CA Screening Recs Will Up Diagnoses

May 16, 2014

Study suggests more cases will be diagnosed at earlier stage; increase in Medicare expenditure

ASCO: New Advanced Lung Cancer Treatments Promising

Nov 30, 2015

But hormone therapy among menopausal women with lung cancer linked to higher risk of death

ASCO: Breath Test May Help Spot Lung Cancer

Jun 3, 2014

Researchers report test could also differentiate early and late stages of the disease